LONDON - The UK government has removed the last legal barrier to stem cell research using human embryos, paving the way for the UK to take the lead in this field as the only country with a precise regulatory framework governing such research. (BioWorld International)
LONDON - Oxford BioMedica plc said it achieved positive interim results from Phase I/II trials of MetXia and TroVax, showing the two cancer gene therapy products were safe and prompted clinical improvements in several of those treated. (BioWorld International)
LONDON - Oxford BioMedica plc said it achieved positive interim results from Phase I/II trials of MetXia and TroVax, showing the two cancer gene therapy products were safe and prompted clinical improvements in several of those treated. (BioWorld International)
